237 related articles for article (PubMed ID: 9827359)
1. Immunophenotype, ras oncogenes and p53 onco-suppressor gene in benzo(a)pyrene induced malignant soft tissue tumours in Wistar rats.
Stefanou DG; Nonni AV; Kalpouzos G; Evangelou A; Agnantis NJ
In Vivo; 1998; 12(5):511-21. PubMed ID: 9827359
[TBL] [Abstract][Full Text] [Related]
2. Leiomyosarcomas: three cases with desmin positive tumour cells, lacking ultrastructural features of smooth muscle cells.
Roholl PJ; de Jong AS; Albus-Lutter CE; van Unnik JA
Histol Histopathol; 1988 Oct; 3(4):389-94. PubMed ID: 2980248
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
[TBL] [Abstract][Full Text] [Related]
5. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
[TBL] [Abstract][Full Text] [Related]
6. p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus.
Jeffers MD; Farquharson MA; Richmond JA; McNicol AM
J Pathol; 1995 Sep; 177(1):65-70. PubMed ID: 7472782
[TBL] [Abstract][Full Text] [Related]
7. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
8. Low-grade abdominopelvic sarcoma with myofibroblastic features (low-grade myofibroblastic sarcoma): clinicopathological, immunohistochemical, molecular genetic and ultrastructural study of two cases with literature review.
Agaimy A; Wünsch PH; Schroeder J; Gaumann A; Dietmaier W; Hartmann A; Hofstaedter F; Mentzel T
J Clin Pathol; 2008 Mar; 61(3):301-6. PubMed ID: 17513510
[TBL] [Abstract][Full Text] [Related]
9. Rhabdoid features in leiomyosarcoma of soft tissue: with special reference to aggressive behavior.
Oshiro Y; Shiratsuchi H; Oda Y; Toyoshima S; Tsuneyoshi M
Mod Pathol; 2000 Nov; 13(11):1211-8. PubMed ID: 11106079
[TBL] [Abstract][Full Text] [Related]
10. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of putative molecular biomarkers in abdominal and retroperitoneal leiomyosarcomas.
Shpitz B; Tiomkin V; Bomstein Y; Gralkin M; Buklan H; Bernheim J; Klein E
Eur J Surg Oncol; 2001 Mar; 27(2):203-8. PubMed ID: 11289760
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of P21ras and P53 proteins expression in human non-small-cell lung cancers.
Przybojewska B; Rydzynski K; Stepnik M; Jakubiak M; Kozak J; Szymczak W
Neoplasma; 2003; 50(3):198-203. PubMed ID: 12937853
[TBL] [Abstract][Full Text] [Related]
14. Presarcomatous lesions of experimentally induced sarcomas in rats: morphologic, histochemical, and immunohistochemical features.
Richter KK; Parham DM; Scheele J; Hinze R; Rath FW
In Vivo; 1999; 13(4):349-55. PubMed ID: 10586377
[TBL] [Abstract][Full Text] [Related]
15. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
Mittal K; Demopoulos RI
Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
[TBL] [Abstract][Full Text] [Related]
16. Expression of oncogenes and tumor suppressor genes in lungs of rats exposed to sulfur dioxide and benzo(a)pyrene.
Qin G; Meng Z
Inhal Toxicol; 2010 Mar; 22(4):322-9. PubMed ID: 20064080
[TBL] [Abstract][Full Text] [Related]
17. [Quantitative studies of oncogene ras P21 and P53 gene protein expression in the benign and malignant pleomorphic adenomas of salivary gland].
Wang J; Dong F; Wang X
Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Jul; 32(4):208-11. PubMed ID: 10680505
[TBL] [Abstract][Full Text] [Related]
18. Expression of ras Rb1 and p53 proteins in human breast cancer.
Spandidos DA; Karaiossifidi H; Malliri A; Linardopoulos S; Vassilaros S; Tsikkinis A; Field JK
Anticancer Res; 1992; 12(1):81-9. PubMed ID: 1567185
[TBL] [Abstract][Full Text] [Related]
19. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
Ward JM; Perantoni AO; Santos E
Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
[TBL] [Abstract][Full Text] [Related]
20. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases.
Barbashina V; Benevenia J; Aviv H; Tsai J; Patterson F; Aisner S; Cohen S; Fernandes H; Skurnick J; Hameed M
J Cancer Res Clin Oncol; 2002 Nov; 128(11):610-6. PubMed ID: 12458341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
